Invest in your Financial Future for FREE

Learn everything you need to know in '9 Secrets of Successful Wealth Management' for FREE from The Successful Investor.

Secrets of Successful Wealth Management: 9 steps to the life you've always wanted, before and after retirement.

 I consent to receiving information from The Successful Investor via email. I understand I can unsubscribe from these updates at any time.

Topic: Wealth Management

A Stock to Sell: Recovering from plant explosion is a big hurdle for this stock

Investment AdviceEvery Monday we feature “A Stock to Sell” as our daily post. With every stock we recommend as a sell, we give you a full explanation of why we advise against investing in the stock at this time.

NEPTUNE TECHNOLOGIES & BIORESSOURCES INC. (symbol NTB on Toronto; www.neptunebiotech.com), makes omega-3 dietary supplements using a patented process for extracting oil from krill. (Krill are shrimp-like deepwater invertebrates that range in length from half an inch to two-and-a-half inches.)

Omega-3 fatty acids reportedly help lower cholesterol and blood pressure when used as a dietary supplement.

The company sells its supplements as bulk oil to a network of distributors who package and sell them under their own labels to customers who are mainly in the U.S., Europe and Australia.

Neptune’s subsidiaries, Acasti Pharma and NeuroBioPharm, are pursuing opportunities in the medical, food and pharmaceutical markets using a highly purified omega-3 concentrate derived from krill oil. Acasti focuses on the treatment of cardiometabolic conditions (diabetes, heart disease and stroke), and NeuroBioPharm focuses on neurological disorders.

The company first sold shares to the public at $1 and began trading on Toronto in May 2001.


Pat McKeough’s solution to your problem

Instead of getting the best investments for their needs, many investors are trapped with a narrow choice dictated by conflicts of interest. That’s one of the main reasons I offer portfolio management advice to a private group of investors, my Wealth Management clients.

We have eliminated any conflict of interest. We are obligated to no outside source. You can have me build you a portfolio that’s tailored to your specific goals, temperament and financial situation. You will get the best investments for you based solely on our judgment and experience.

You will be in very secure hands. We have an outstanding team of experts. And I personally approve every transaction in every portfolio. Click here to learn more about our Successful Investor portfolio management services.


Investing advice: New share issue generates cash to sustain company as it loses money

On November 8, 2012, an explosion destroyed Neptune’s only plant, in Sherbrooke, Quebec. While the company rebuilt the facility, it generated revenue by selling krill oil it had acquired through short-term arrangements, as well as through a manufacturing and supply agreement signed with Rimfrost USA, LLC, in October 2013.

These arrangements, along with price concessions, let Neptune maintain a significant portion of its pre-explosion revenue. The company announced that it had resumed production at its Sherbrooke plant in June 2014.

In the three months ended May 31, 2014, Neptune’s sales fell sharply, to $3.7 million from $6.1 million a year earlier. The company lost $4.3 million, or $0.06 a share, compared to a loss of $5.4 million, or $0.07.

After a share issue in March 2014, Neptune holds cash of $51.9 million, or $0.70 a share. Its $10.2 million of debt is a low 6.4% of its $159.7-million market cap.

The company’s high cash balance will help sustain it as it continues to lose money. But in order to become profitable, Neptune will need to re-establish and expand its customer base and increase its sales.

Meanwhile, it faces competition from other natural food supplement suppliers, as well as products developed by the pharmaceutical industry that have proven scientific credibility.

We don’t recommend Neptune Technologies & Bioressources. If you own the stock we think you should sell.

P.S. Take advantage of our 4-day Flash Sale, Friday, Saturday, Sunday and Monday. Stock Pickers Digest (including our views on Tim Hortons merger talks)—just $29 for six months. Click here for this special limited offer.

Comments

Tell Us What YOU Think

You must be logged in to post a comment.

Please be respectful with your comments and help us keep this an area that everyone can enjoy. If you believe a comment is abusive or otherwise violates our Terms of Use, please click here to report it to the administrator.